Pharmacotherapy in the Management of Obesity

JAMA: The Journal of the American Medical Association

Volumn 277, Issue 15, 1997, Pages 1201-

  Tiedt, Thomas N ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANOREXIGENIC AGENT; DEXFENFLURAMINE; FENFLURAMINE; PHENTERMINE;

HUMAN; NOTE; OBESITY; DIETARY INTAKE; DRUG MARKETING; DRUG USE; LETTER; PHYSICAL ACTIVITY; PRIORITY JOURNAL;

APPETITE DEPRESSANTS; HUMANS; OBESITY;

EID: 0030903439     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1997.03540390031024     Document Type: Letter

References (6)

1. National Task Force on the Prevention and Treatment of Obesity. Long-term pharmacotherapy in the management of obesity. JAMA. 1996;276:1907-1915.
2. Atkinson RL, Hubbard VS. Report on the NIH workshop on pharmacologic treatment of obesity. Am J Clin Nutr. 1994;60:153-156.
3. NIH Technology Assessment Conference Panel. Methods for voluntary weight loss and control. Ann Intern Med. 1993;119:764-770.
4. Bray GA, Inoue S. Pharmacological treatment of obesity. Am J Clin Nutr. 1992; 55:VI.
5. Saal M. Utah pharmacist seeing frenzy for diet pills: physicians worried that fenphen craze may lead to abuse of drugs. Standard Examiner. September 26, 1996; local section.
6. Weintraub M. Long-term weight control study. Clin Pharmacol Ther. 1992;51: 642-646.